SYSBIOTECH
Private Company
Total funding raised: $3.3M
Overview
Founded in 2010 and based in Graz, Austria, SYSBIOTECH operates as a specialized equipment and solutions provider for the biotech industry, particularly in synthetic biology and biologics manufacturing. The company's core business is designing and supplying customizable fermentation and downstream processing systems, from benchtop to industrial scale. It has demonstrated relevance in critical areas, such as supplying equipment for COVID-19 vaccine manufacturing, and actively participates in major industry events like ACHEMA. SYSBIOTECH appears to be a private, revenue-generating company serving research institutes and production facilities.
Technology Platform
Integrated bioprocessing equipment platform for fermentation, separation, filtration, and lyophilization across lab, pilot, and industrial scales.
Funding History
2Opportunities
Risk Factors
Competitive Landscape
SYSBIOTECH competes in the fragmented bioprocess equipment market against major multinational corporations (e.g., Sartorius, Thermo Fisher) and other specialized European engineering firms. Its differentiation likely lies in customization, integrated solutions, and focus on the pilot-scale bridge between R&D and production.